EUVIMEDEUVIMED entdecken
Open Access

GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy

Tristan M Sissung, Sarah Lochrin, Tyler Liu, Keith Schmidt, Jonathan Strope, Emily Risdon, Hyoyoung Choo-Wosoba, David J Venzon, Wiem Lassoued, Houssein A Sater, Beatriz Walter-Rodriguez, Douglas K Price und 1 weitere

Anticancer Research · 2023

DOI: 10.21873/anticanres.16590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Tristan M Sissung und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Hyperplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic HyperplasiaAnimalsMaleHumansAndrogen AntagonistsGonadotropin-Releasing HormoneAndrogensMammals

Stichwörter der Autor:innen

GNRH2androgen deprivation therapyprostate cancersurvival

Substanzen

Androgen AntagonistsGonadotropin-Releasing HormoneAndrogens

Autor:innen und Institutionen

  • Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A. figgw@mail.nih.gov.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Sissung, T. M., Lochrin, S., Liu, T., Schmidt, K., Strope, J., Risdon, E., Choo-Wosoba, H., Venzon, D. J., Lassoued, W., Sater, H. A., Walter-Rodriguez, B., Price, D. K., & Figg, W. D. (2023). GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy. Anticancer Research. https://doi.org/10.21873/anticanres.16590

Vancouver

Sissung TM, Lochrin S, Liu T, Schmidt K, Strope J, Risdon E, et al. GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy. Anticancer Research. 2023. doi:10.21873/anticanres.16590

BibTeX
@article{Sissung2023,
  author = {Sissung, Tristan M and Lochrin, Sarah and Liu, Tyler and Schmidt, Keith and Strope, Jonathan and Risdon, Emily and Choo-Wosoba, Hyoyoung and Venzon, David J and Lassoued, Wiem and Sater, Houssein A and Walter-Rodriguez, Beatriz and Price, Douglas K and Figg, William D},
  title = {GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16590}
}
Kostenlos starten →